Related Experiment Video
Updated: Mar 30, 2026

An ELISA Based Binding and Competition Method to Rapidly Determine Ligand-receptor Interactions
Published on: March 14, 2016
Instructive roles for cytokine-receptor binding parameters in determining signaling and functional potency
Ignacio Moraga1, David Richter2, Stephan Wilmes2
1Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA 94305-5345, USA. Department of Molecular and Cellular Physiology and Department of Structural Biology, Stanford University School of Medicine, Stanford, CA 94305-5345, USA.
Cytokine therapies are challenging due to pleiotropy. This study engineered interleukin-13 (IL-13) variants to understand how receptor binding affects immune cell signaling, revealing key parameters for optimizing cytokine treatments.
Area of Science:
- Immunology
- Molecular Biology
- Biochemistry
Background:
- Cytokines regulate immune responses but their pleiotropic effects complicate therapies.
- High doses of cytokines can cause off-target effects, necessitating a deeper understanding of signaling.
- Interleukin-13 (IL-13) is a model cytokine with diverse biological activities.
Purpose of the Study:
- To investigate the relationship between cytokine receptor binding affinity and downstream signaling.
- To explore how variations in IL-13 binding strength affect STAT6 activation and cellular responses.
- To develop a mechanistic model for cytokine-induced signaling kinetics.
Main Methods:
- Structure-based engineering of IL-13 variants with varying affinities for IL-13Rα1.
- Assessing STAT6 phosphorylation and nuclear translocation kinetics in response to engineered IL-13 variants.
- Developing a quantitative mechanistic model to predict signaling kinetics based on binding affinity.
Main Results:
- Engineered IL-13 variants showed similar STAT6 phosphorylation potency across a range of binding affinities.
- Significantly reduced receptor affinities led to delays in STAT6 phosphorylation and nuclear translocation.
- Receptor endocytosis and receptor-ligand complex lifetime were identified as critical modulators of STAT6 activation and distal responses.
- A mechanistic model accurately reproduced STAT6 phosphorylation kinetics across all tested binding affinities.
Conclusions:
- Cytokine receptor binding affinity is not the sole determinant of signaling potency.
- Receptor dynamics, including endocytosis and complex lifetime, significantly influence downstream signaling outcomes.
- Understanding these complex interrelationships can inform mechanism-based strategies for optimizing cytokine dosage and therapeutic efficacy.
More Related Videos
14:09Fluorescence Biomembrane Force Probe: Concurrent Quantitation of Receptor-ligand Kinetics and Binding-induced Intracellular Signaling on a Single Cell
Published on: August 4, 2015
07:39Determining Binding Affinity KD of Radiolabeled Antibodies to Immobilized Antigens
Published on: June 23, 2022
Related Concept Videos
The JAK-STAT Signaling Pathway
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
The Equilibrium Binding Constant and Binding Strength
The Equilibrium Binding Constant and Binding Strength
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...